Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Mild to Moderate Pneumonia in Adult Patients

ClinicalTrials.gov ID: NCT00643734

Public ClinicalTrials.gov record NCT00643734. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 8:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Double-Dummy Comparative Trial of Azithromycin SR Versus Levofloxacin for the Treatment of Mild to Moderate Community-Acquired Pneumonia in Adults

Study identification

NCT ID
NCT00643734
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
468 participants

Conditions and interventions

Conditions

Interventions

  • azithromycin sustained release Drug
  • placebo Other
  • levofloxacin Drug

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2003
Primary completion
Not listed
Completion
Mar 31, 2004
Last update posted
Mar 25, 2008

2003 – 2004

United States locations

U.S. sites
35
U.S. states
23
U.S. cities
31
Facility City State ZIP Site status
Pfizer Investigational Site Mesa Arizona 85206
Pfizer Investigational Site Phoenix Arizona 85014
Pfizer Investigational Site San Luis Obispo California 93401
Pfizer Investigational Site San Mateo California 94403
Pfizer Investigational Site Highlands Ranch Colorado 80130
Pfizer Investigational Site Newark Delaware 19702
Pfizer Investigational Site Kissimmee Florida 34741
Pfizer Investigational Site Merrit Island Florida 32953
Pfizer Investigational Site Evansville Indiana 47712
Pfizer Investigational Site Evansville Indiana 47714
Pfizer Investigational Site Indianapolis Indiana 46254
Pfizer Investigational Site Dubuque Iowa 52001
Pfizer Investigational Site Pratt Kansas 67124
Pfizer Investigational Site Madisonville Kentucky 42431
Pfizer Investigational Site Cumberland Maryland 21502
Pfizer Investigational Site Kalamazoo Michigan 49009
Pfizer Investigational Site Olive Branch Mississippi 38654
Pfizer Investigational Site Elkhorn Nebraska 68022
Pfizer Investigational Site Omaha Nebraska 68144
Pfizer Investigational Site Rio Rancho New Mexico 87124
Pfizer Investigational Site Charlotte North Carolina 28209
Pfizer Investigational Site Charlotte North Carolina 28210
Pfizer Investigational Site Charlotte North Carolina 28262
Pfizer Investigational Site Hickory North Carolina 28601
Pfizer Investigational Site Yukon Oklahoma 73099
Pfizer Investigational Site Downingtown Pennsylvania 19335
Pfizer Investigational Site King of Prussia Pennsylvania 19406
Pfizer Investigational Site Morrisville Pennsylvania 19067
Pfizer Investigational Site Greer South Carolina 29651
Pfizer Investigational Site Dyersburg Tennessee 38024
Pfizer Investigational Site Lake Jackson Texas 77566
Pfizer Investigational Site Salt Lake City Utah 84109
Pfizer Investigational Site Salt Lake City Utah 84121
Pfizer Investigational Site Walla Walla Washington 99362
Pfizer Investigational Site Menomonee Falls Wisconsin 53051

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 30 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00643734, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 25, 2008 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00643734 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →